Literature DB >> 1927530

Bones for the future.

I T Boyle1.   

Abstract

In the course of the present century the major metabolic bone problem in the West of Scotland and Northern Europe in general has changed from that of rickets/osteomalacia with its attendant deformity and loss of stature, to osteoporosis and a consequent epidemic of fractures in older people. Advances in understanding the intermediary metabolism of vitamin D have resulted in a better appreciation of the role of air pollution in the rickets pandemic during the latter part of the 19th and early part of the 20th century, but the persistence of the problem in Asian immigrants and in certain special clinical situations had led to a reappraisal of the importance of dietary constituents other than vitamin D itself. Technical advances in the measurement of bone mass have permitted a closer examination of the aetiological factors influencing bone mass and fracture incidence. It seems likely that there is a relationship between increased dietary calcium intake in childhood and adolescence and peak bone mass in the fourth decade, but the definition of "adequate" and "optimum" remains insecure. The most important reason for women becoming at risk of fracture in later life relates to the dramatic reduction in bone mass consequent upon the menopause--a feature which can be arrested by the administration of oestrogen but hardly at all by calcium. The bulk of evidence supports the view that the negative calcium balance found in post menopausal osteoporosis is a consequence rather than a cause, and that dietary calcium can only--if at all--influence the course of events if pushed up to unusually--and for many, intolerably--high levels. Although other life style components such as exercise, alcohol consumption or cigarette smoking may also have a role, the principal impact on reducing the problem of post menopausal fracture is likely to be through the wider acceptance of hormone replacement therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1927530     DOI: 10.1111/j.1651-2227.1991.tb18152.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand Suppl        ISSN: 0300-8843


  5 in total

1.  Serum carcinoembryonic antigen-related cell adhesion molecule 1 level in postmenopausal women: correlation with β-catenin and bone mineral density.

Authors:  C Ma; B Shuai; L Shen; Y P Yang; X J Xu; C G Li
Journal:  Osteoporos Int       Date:  2015-11-16       Impact factor: 4.507

Review 2.  The peak bone mass concept: is it still relevant?

Authors:  Eckhard Schönau
Journal:  Pediatr Nephrol       Date:  2004-06-09       Impact factor: 3.714

3.  Reduced bone mineral content and normal serum osteocalcin in non-steroid-treated patients with juvenile rheumatoid arthritis.

Authors:  C Polito; C G Strano; L Rea; M Alessio; C S Iammarrone; N Todisco; A Marotta; E Iaccarino; M Pirozzi
Journal:  Ann Rheum Dis       Date:  1995-03       Impact factor: 19.103

4.  Cost-utility of denosumab for the treatment of postmenopausal osteoporosis in Spain.

Authors:  Josep Darbà; Lisette Kaskens; Francesc Sorio Vilela; Mickael Lothgren
Journal:  Clinicoecon Outcomes Res       Date:  2015-02-09

Review 5.  "English Disease": Historical Notes on Rickets, the Bone-Lung Link and Child Neglect Issues.

Authors:  Mingyong Zhang; Fan Shen; Anna Petryk; Jingfeng Tang; Xingzhen Chen; Consolato Sergi
Journal:  Nutrients       Date:  2016-11-15       Impact factor: 5.717

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.